Gatifloxacin-based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication

被引：0
|
作者：
Sharara, AI
Chaar, HF
Aoun, E
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[2] Lebanese Amer Univ, Beirut, Lebanon
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
10.14309/00000434-200410001-00114
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
114
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Nakagawa, Izumi
    Iwasaki, Eisuke
    Masaoka, Tatsuhiro
    Hibi, Toshifumi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : S167 - S170
  • [2] Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
    Watanabe, Y
    Aoyama, N
    Shirasaka, D
    Maekawa, S
    Kuroda, K
    Miki, I
    Kachi, M
    Fukuda, M
    Wambura, C
    Tamura, T
    Kasuga, M
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (10) : 711 - 715
  • [3] Levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication:: Update
    Finizio, R
    Nista, EC
    Candelli, M
    Zocco, MA
    Ojetti, V
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. HELICOBACTER, 2005, 10 (05) : 528 - 528
  • [4] Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy
    Togawa, J
    Inamori, M
    Fujisawa, N
    Takahashi, H
    Yoneda, M
    Kawamura, H
    Abe, Y
    Kirikoshi, H
    Kobayashi, N
    Sakaguchi, T
    Takamura, T
    Nakajima, A
    Ueno, N
    Sekihara, H
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (62) : 645 - 648
  • [5] Second-line Helicobacter pylori therapy for eradication failure in children
    Saltik-Temizel, I. N.
    Usta, Y.
    Demir, H.
    Uslu, N.
    Yuce, A.
    Gurakan, F.
    Ozen, H.
    [J]. HELICOBACTER, 2007, 12 (04) : 432 - 433
  • [6] SECOND-LINE RESCUE THERAPY WITH LEVOFLOXACIN AND BISMUTH AFTER FAILURE OF A HELICOBACTER PYLORI ERADICATION TREATMENT
    Gisbert, J. P.
    Solis-Munoz, P.
    Romano, M.
    Gravina, A.
    Lucendo, A.
    Molina-Infante, J.
    Velayos, B.
    Herranz, M.
    Barrio, J.
    Modolell, I.
    Gomez, J.
    Del Castillo, F.
    Dominguez, J. L.
    Federico, A.
    Martorano, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Miranda, A.
    Marin, A. C.
    McNicholl, A. G.
    [J]. HELICOBACTER, 2014, 19 : 135 - 135
  • [7] Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori
    Mori, Naoyoshi
    Nishiura, Yuuki
    Suga, Daisuke
    Moritani, Isao
    Yamanaka, Yutaka
    Ooya, Yumi
    Inoue, Hidekazu
    Takase, Koujirou
    Hioki, Masato
    Shiraki, Katsuya
    [J]. BIOMEDICAL REPORTS, 2018, 9 (02) : 169 - 174
  • [8] 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication
    Nista, EC
    Candelli, M
    Fini, L
    Cazzato, IA
    Finizio, R
    Lauritano, C
    Cammarota, G
    Martino, A
    Gasbarrini, G
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A74 - A74
  • [9] 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication
    Nista, EC
    Cazzato, IA
    Di Caro, S
    Candelli, M
    Ojetti, V
    Gabrielli, M
    Santarelli, L
    Nista, R
    Fini, L
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A359 - A359
  • [10] THE EFFECT OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI ERADICATION INFECTION
    Hwang, J.
    Lee, D.
    Yoon, K.
    Lee, H.
    Jeong, Y.
    Kwon, Y.
    Lee, A.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    Seol, S.
    Jung, H.
    [J]. HELICOBACTER, 2014, 19 : 139 - 139
12345